Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) shares saw unusually-strong trading volume on Tuesday. Approximately 2,062,834 shares were traded during trading, an increase of 238% from the average daily volume of 610,661 shares. The stock last traded at $15.22 and had previously closed at $15.15.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the company. BNP Paribas Exane downgraded Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a report on Wednesday, September 2nd. Zacks Research raised Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research report on Friday, August 28th. Jefferies Financial Group raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Tuesday, July 21st. The Goldman Sachs Group upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, October 7th. Finally, UBS Group reissued a “buy” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, October 28th. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.
Check Out Our Latest Stock Analysis on RBGLY
Reckitt Benckiser Group Stock Performance
The company has a quick ratio of 0.40, a current ratio of 0.59 and a debt-to-equity ratio of 1.31. The business has a 50-day moving average of $14.02 and a 200-day moving average of $14.11.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc, which operates under the Reckitt name, is a global consumer goods company focused on health, hygiene and nutrition. Its products include household cleaning and disinfecting goods, personal care items, over-the-counter medicines and infant formula. The company’s portfolio includes brands such as Dettol, Lysol, Finish, Durex, Strepsils, Nurofen and Enfamil. Its products are sold in markets around the world through retailers, pharmacies and other distribution channels. Reckitt was formed in 1999 through the merger of British company Reckitt & Colman and Dutch company Benckiser.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Archer Aviation’s FAA Certificate Is a Milestone, But It Isn’t the Final One
- Microsoft’s Neocloud Pullback Isn’t a Crack in AI Demand
- Fox’s $22 Billion Roku Acquisition Reshapes Its Streaming Business
- DraftKings Just Lost 20%—And Its Biggest Gamble Is Still Ahead
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
